Verma S, McGuire DK, Bain SC, Bhatt DL, et al. Effects of glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 diabetes: results of the LEADER and SUSTAIN 6 trials. Diabetes Obes Metab 2020 Aug 3. doi: 10.1111/dom.14160.
PMID: 32744418